Sunil Singhal

University of Pennsylvania
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (47)

Purpose: Osteosarcoma is the most common primary malignancy of the skeleton. Despite advances in imaging modalities, neoadjuvant and adjuvant chemotherapy, and limb-sparing surgery over the past decades, there has been a general lack of improvement in survival rates. Tumor recurrence and metastases are associated with a worse prognosis, and complete tumor excision is critical. The use of real-time imaging could facilitate the acquisition of tumor-free surgical margins. Spontaneous osteosarcoma in dogs is an established translational model of human osteosarcoma. Experimental Design: In this study, 12 dogs with spontaneous appendicular osteosarcoma received a cathepsin-targeted quenched activity-based probe (VGT-309) intravenously 16 to 20 hours before amputation. The limb was imaged at four levels of dissection, and the margins of near-infrared fluorescence were marked for comparison with histopathology and preoperative MRI. Results: All appendicular tumors fluoresced on cross-section of the bone, and the extent of fluorescence coincided with MRI and histopathologic margins, with variability associated with necrosis. All tumors had visible fluorescence through cortical bone, although this did not consistently reflect intramedullary extension of the tumor. Necrotic tumor regions did not fluoresce. Conclusions: These data support the safety and feasibility of VGT-309 as a tool for evaluating the tissue extent of canine osteosarcoma and spur investigation for intraoperative detection of osteosarcoma during limb-sparing surgery in humans. Due to frequent intramedullary tumor extension and inconsistent fluorescence through unaffected cortical bone, this modality is likely most appropriate for assessing residual tumor following planned resection. Caution should be exercised when significant tumor necrosis is present.

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Regulatory T cells (Tregs) are essential for maintaining immune tolerance but also contribute to immune suppression within the tumor microenvironment (TME), dampening antitumor immunity in hematologic and solid tumors. As such, strategies aimed at depleting Tregs or reducing their suppressive activity are of great clinical interest. CC chemokine receptor 4 (CCR4) is highly expressed on intratumoral Tregs and mediates Treg migration into the TME. Although current therapies targeting CCR4 using monoclonal antibodies have shown some Treg depletion in clinical trials, their clinical efficacy has been limited. We therefore tested whether chimeric antigen receptor (CAR) T-cell (CART) therapy could be used to deplete Tregs. We evaluated human-specific CCR4-directed CARTs (CCR4-CARTs) previously developed for T-cell malignancies and determined whether these CARTs could deplete human Tregs ex vivo and in vivo. In patient-derived malignant pleural effusions and lung cancer tumor digests, CCR4-CARTs almost completely depleted Tregs, along with a small population of CCR4+CD4+ non-Tregs, while sparing CD8+ T cells. When tested in vivo in humanized mice, a single dose of CCR4-CARTs led to nearly complete Treg depletion. These findings support the potential of CCR4-CARTs as a selective and effective approach to Treg modulation and warrant further clinical investigation.

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (18)

Gwendolyn Cramer

The Wistar Institute

UNITED STATES
View details

Danielle Reed

Member

Monell Chemical Senses Center

UNITED STATES
View details

Sandy Widura

The Wistar Institute

UNITED STATES
View details

Brian K. Flesner

-

UNITED STATES
View details

David Forsyth

Professor

University of Illinois at Urbana-Champaign

UNITED STATES
View details

Susan R. Weiss

University of Pennsylvania Perelman School of Medicine

UNITED STATES
View details

Shuming Nie

Professor

University of Illinois at Urbana-Champaign

UNITED STATES
View details

Andrew Kossenkov

Assistant Professor

The Wistar Institute

UNITED STATES
View details

Theresa M. Busch

University of Pennsylvania

UNITED STATES
View details

Steven Albelda

Professor

University of Pennsylvania

UNITED STATES
View details

Wilfried Mai

Professor of Radiology

University of Pennsylvania

UNITED STATES
View details

Dr. Ranawaka A.P.M Perera

Assistant Professor/ Scientific Director BSL3 laboratory

University of Pennsylvania Perelman School of Medicine

UNITED STATES
View details

Mary E. Putt

Professor

University of Pennsylvania

UNITED STATES
View details

Emmanouil Papasavvas

The Wistar Institute

UNITED STATES
View details

Viktor Gruev

University of Illinois at Urbana-Champaign

UNITED STATES
View details

George Georgiou

Professor

University of Texas at Austin

UNITED STATES
View details

Maureen A. Griffin

University of Pennsylvania

UNITED STATES
View details

Charles W. Bradley

University of Pennsylvania

UNITED STATES
View details